TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
Automation of NGS library preparation is becoming a critical enabler for high‑throughput genomics projects, as laboratories seek to scale up sequencing while minimizing hands‑on time and error rates. The rapid adoption of precision‑medicine and population‑wide genomics initiatives fuels demand for reliable, modular platforms that can handle diverse sample types, including DNA, RNA, and ChIP.
Key growth drivers include decreasing sequencing costs, expanding clinical‑testing applications, and the need for reproducible data pipelines. However, challenges such as high capital expenditure, integration with existing laboratory information management systems, and the requirement for skilled personnel may temper adoption in smaller facilities.
Vendors are responding with flexible, scalable designs, subscription‑based service models, and strategic partnerships to accelerate market penetration across both research and clinical segments.
Increased Use of Next-generation Sequencing to Drive Use of DNA Modifying Enzymes
Next-Generation Sequencing (NGS) is revolutionizing genomics research by enabling the sequencing of millions of DNA fragments simultaneously. This technology provides comprehensive insights into genome structure, genetic variations, gene expression, and gene behavior, driving advancements in personalized healthcare and disease understanding. Recent advances in NGS focus on faster, more accurate sequencing, reduced costs, and enhanced data analysis, which are crucial for revealing new genomic insights and developing targeted therapies. Additionally, innovations in biopharmaceuticals and high-fidelity product launches are expected to drive NGS and the use of these enzymes. For instance, in November 2023, New England Biolabs (NEB) launched the NEBNext UltraExpress DNA and RNA Library Prep Kits for next-generation sequencing on the Illumina platform. Such advancements are expected to fuel the market growth.
Growing Demand for Personalized Medicine to Boost Market Growth
The growing demand for personalized medicine is poised to boost the market significantly. Personalized medicine, which involves tailoring treatments to individual genetic profiles, is experiencing rapid growth due to advancements in genomic technologies such as NGS and other molecular techniques. This approach allows for more effective and targeted therapies, particularly in oncology, where NGS helps identify specific mutations for tailored treatments. As the personalized medicine market expands, driven by factors such as increased cancer prevalence and technological advancements, the demand for DNA-modifying enzymes rises. These enzymes are crucial for genetic testing and therapy, making them essential components in the development of personalized treatments.
Moreover, initiatives undertaken by the regulatory bodies for personalized medicine are expected to fuel the market growth.
➤ For instance, the U.S. Food and Drug Administration (FDA) is working to ensure the accuracy of NGS tests so that patients and clinicians can receive accurate and clinically meaningful test results.
Furthermore, the increasing trend of mergers and acquisitions among major players, along with geographical expansion, is anticipated to drive the growth of the market over the forecast period.
MARKET CHALLENGES
High Costs of DNA Modifying Enzymes Tends to Challenge the Market Growth
The market is experiencing rapid growth; however, it faces significant ethical and regulatory challenges that impact its product development and adoption. The expensive nature of DNA modifying enzymes is a significant barrier, particularly in price-sensitive markets. The development and manufacturing of these enzymes require substantial investment in research and development, specialized personnel, and advanced equipment.
Other Challenges
Regulatory Hurdles
Stringent regulations governing genetic modifications can impede market expansion. Navigating complex regulatory frameworks is costly and time‑consistent, which may deter companies from investing in these technologies.
Ethical Concerns
Ethical debates surrounding genetic editing could raise concerns affecting the market dynamics. The long‑term safety and potential unintended effects of gene editing technologies such as CRISPR‑Cas9 are subjects of ongoing ethical discussions which can be a potential challenge for the market.
Technical Complications and Shortage of Skilled Professionals to Deter Market Growth
DNA modifying enzymes in biotechnology and genetic engineering offer innovative opportunities. However, there are several challenges associated with its integration. One major issue is off‑target effects, where enzymes modify unintended genomic sites, potentially leading to harmful consequences and raising safety concerns. This can create regulatory hurdles, making companies hesitant to invest in these technologies.
Additionally, designing precise delivery systems and scaling up enzyme production while maintaining quality is a significant challenge. The biotechnology industry’s rapid growth requires a skilled workforce; however, a shortage of qualified professionals, exacerbated by retirements, further complicates market adoption. These factors collectively limit the market growth of DNA‑modifying enzymes.
Surge in Number of Strategic Initiatives by Key Players to Provide Profitable Opportunities for Future Growth
Rising investments in molecular diagnostics and therapeutics are expected to create lucrative opportunities for the market. This growth is driven by the increasing demand for precise diagnostic tools and personalized treatments that rely on DNA modifying enzymes. Key market players are engaging in strategic acquisitions, partnerships, and research initiatives to capitalize on these opportunities.
Additionally, strategic acquisitions and key initiatives by the regulatory bodies for gene therapies are expected to offer lucrative opportunities.
The global Automated NGS Library Preparation System market was valued at 902 million in 2025 and is projected to reach US$ 2013 million by 2032, at a CAGR of 12.5% during the forecast period. The automated NGS library preparation system is an automated device that integrates high‑throughput sequencing sample processing and can automatically complete the entire process from sample preparation to library construction. Its advantage is that it greatly improves the efficiency and accuracy of library construction and reduces the complexity and error probability of manual operations. Features include high‑speed automated operation, flexible modular design, precise liquid handling capabilities, and powerful data processing functions, which enable the automated NGS library construction system to meet the growing sequencing needs and provide strong technical support for research in genomics, genetics and other fields. The U.S. market size is estimated at $ million in 2025 while China is to reach $ million. DNA Library Preparation segment will reach $ million by 2032, with a % CAGR in next six years. The global key manufacturers of Automated NGS Library Preparation System include Perkin Elmer, Agilent Technologies, Tecan, Illumina, Roche, Takara Bio USA, Aurora Biomed, Hamilton, Revvity, Beckman Coulter, etc. In 2025, the global top five players had a share approximately % in terms of revenue. We have surveyed the Automated NGS Library Preparation System manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. This report aims to provide a comprehensive presentation of the global market for Automated NGS Library Preparation System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automated NGS Library Preparation System. This report contains market size and forecasts of Automated NGS Library Preparation System in global, including the following market information: Global Automated NGS Library Preparation System market revenue, 2021‑2026, 2027‑2032, ($ millions); Global Automated NGS Library Preparation System market sales, 2021‑2026, 2027‑2032, (Units); Global top five Automated NGS Library Preparation System companies in 2025 (%); Total Market by Segment: Global Automated NGS Library Preparation System market, by Product Type, 2021‑2026, 2027‑2032 ($ millions) & (Units); Global Automated NGS Library Preparation System market segment percentages, by Type, 2025 (%): DNA Library Preparation, RNA Library Preparation, ChIP Library Preparation; Global Automated NGS Library Preparation System market, by Application, 2021‑2026, 2027‑2032 ($ Millions) & (Units); Global Automated NGS Library Preparation System market segment percentages, by Application, 2025 (%): Clinical Testing, Scientific Research; Global Automated NGS Library Preparation System market, by region and country, 2021‑2026, 2027‑2032 ($ millions) & (Units); Global Automated NGS Library Preparation System market segment percentages, by region and country, 2025 (%): North America (US, Canada, Mexico), Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Benelux, Rest of Europe), Asia (China, Japan, South Korea, Southeast Asia, India, Rest of Asia), South America (Brazil, Argentina, Rest of South America), Middle East & Africa (Turkey, Israel, Saudi Arabia, UAE, Rest of Middle East & Africa). Competitor Analysis: The report also provides analysis of leading market participants including: Key companies Automated NGS Library Preparation System revenues in global market, 2021‑2026 (estimated), ($ millions); Key companies Automated NGS Library Preparation System revenues share in global market, 2025 (%); Key companies Automated NGS Library Preparation System sales in global market, 2021‑2026 (estimated), (Units); Key companies Automated NGS Library Preparation System sales share in global market, 2025 (%). Further, the report presents profiles of competitors in the market, key players include: Perkin Elmer, Agilent Technologies, Tecan, Illumina, Roche, Takara Bio USA, Aurora Biomed, Hamilton, Revvity, Beckman Coulter, QIAGEN, INTEGRA Biosciences AG, SPT Labtech, AUTOMATA, GUANGDONG MGI TECH, Jiangsu Bioperfectus Technologies, WillingMed Technology (Beijing), Hangzhou Matridx Biotechnology, Shanghai 3D Medicines, MobiDrop (Zhejiang). Outline of Major Chapters: Chapter 1: Introduces the definition of Automated NGS Library Preparation System, market overview. Chapter 2: Global Automated NGS Library Preparation System market size in revenue and volume. Chapter 3: Detailed analysis of Automated NGS Library Preparation System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Automated NGS Library Preparation System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Global Automated NGS Library Preparation System capacity by region & country. Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 11: The main points and conclusions of the report.
The global Automated NGS Library Preparation System market was valued at USD 902 million in 2025 and is projected to reach USD 2,013 million by 2032, growing at a CAGR of 12.5%.
The automated NGS library preparation system integrates high‑throughput sample processing, delivering fully automated library construction from nucleic‑acid extraction to a sequencing‑ready library. Its high‑speed operation, modular design, precise liquid‑handling, and robust data‑processing capabilities reduce manual errors, increase reproducibility, and accelerate research in genomics, genetics, clinical diagnostics, and precision medicine.
Key manufacturers include Perkin Elmer, Agilent Technologies, Tecan, Illumina, Roche, Takara Bio USA, Aurora Biomed, Hamilton, Revvity, Beckman Coulter, QIAGEN, and several emerging innovators.
DNA Polymerases Segment Dominates the Market Due to its Escalated Use in PCR and NGS
The market is segmented based on type into:
DNA ligases
Subtypes: T7 DNA, T4 DNA, and others
DNA polymerases
Exonucleases
Subtypes: Exonucleases I, Exonucleases II, and others
Endonucleases
Subtypes: DNase I and others
Methyltransferase
Inorganic pyrophosphatase
Others
Molecular Diagnostics Segment Leads Due to High Adoption in Disease Detection and Precision Medicine
The market is segmented based on application into:
Molecular diagnostics
Drug discovery and development
Academic and research institutions
Forensics
Agriculture and animal research
Others
Companies Strive to Strengthen their Product Portfolio to Sustain Competition
The global Automated NGS Library Preparation System market was valued at $902 million in 2025 and is projected to reach $2,013 million by 2032, growing at a 12.5% CAGR during the forecast period. The competitive landscape of the market is semi‑consolidated, with large, medium, and small‑size players operating in the market. Thermo Fisher Scientific Inc. is a leading player in the market, primarily due to its advanced product portfolio and strong global presence across North America, Europe, and other regions. Its flagship Ion Chef System integrates high‑throughput sample processing with precise liquid handling, which has helped the company capture a significant share of the burgeoning demand for rapid, reproducible library construction.
Takara Bio Inc. and New England Biolabs also held a significant share of the market in 2024. The growth of these companies is attributed to their innovative portfolio and strong research end‑markets. Takara’s Premier Automated Library Prep system, for example, offers modular flexibility that meets both DNA and RNA library needs, while New England Biolabs’ NEBNext® Automation platforms have been praised for reducing hands‑on time by up to 70 %.
Additionally, these companies' growth initiatives, geographical expansions, and new product launches are expected to grow the market share significantly over the projected period. Recent announcements include Thermo Fisher’s partnership with a major cloud‑computing provider to enhance data‑processing capabilities, and Takara Bio’s entry into the Chinese market with a localized manufacturing hub, reflecting the rising importance of the Asia‑Pacific region where the market is projected to exceed $600 million by 2032.
Meanwhile, Merck KGaA and Promega Corporation are strengthening their market presence through significant investments in R&D, strategic partnerships, and innovative product expansions, ensuring continued growth in the competitive landscape. Merck’s MagNA Pure 96 system now supports seamless integration with Illumina sequencers, and Promega’s recent launch of a high‑throughput ChIP‑Seq automation kit addresses a fast‑growing niche in epigenetics research.
Thermo Fisher Scientific Inc.
Bio‑Rad Laboratories, Inc.
Fortis Life Sciences, LLC.
BioCat GmbH
Takara Bio Inc.
Danaher Corporation
The global Automated NGS Library Preparation System market was valued at US$902 million in 2025 and is projected to reach US$2,013 million by 2032, expanding at a CAGR of 12.5 % over the forecast horizon. This automated device consolidates high‑throughput sample processing, liquid handling, and data analysis to complete the entire workflow from raw sample to ready‑to‑sequence library without manual intervention. By dramatically improving efficiency and reducing error rates, the system meets the surging demand for large‑scale genomics projects in clinical testing, drug discovery, and agricultural research. Key features—high‑speed operation, modular design, precise fluidics, and integrated analytics—enable laboratories to scale throughput while maintaining reproducibility. The rapid adoption of next‑generation sequencing in personalized medicine, population‑scale studies, and emerging infectious‑disease surveillance is a primary catalyst for this growth, driving laboratories to replace labor‑intensive manual protocols with fully automated solutions.
Personalized Medicine
Personalized medicine’s expansion fuels a robust pipeline of demand for automated library preparation. As clinicians increasingly rely on whole‑genome and targeted sequencing to tailor therapies, the need for rapid, high‑quality library generation becomes critical. The market’s DNA Library Preparation segment alone is expected to achieve a strong multi‑digit CAGR, reflecting its central role in both clinical diagnostics and research applications. Simultaneously, RNA and ChIP library preparation modules are gaining traction, supporting transcriptomic and epigenomic profiling. This diversification of assay types amplifies the total addressable market, encouraging vendors to broaden product portfolios and integrate AI‑driven quality control, which further enhances throughput and lowers total cost of ownership.
Intensified R&D activities across academia and industry are accelerating the utilization of automated NGS library systems. The competitive landscape features leading manufacturers such as Perkin Elmer, Agilent Technologies, Tecan, Illumina, Roche, Takara Bio USA, Aurora Biomed, Hamilton, Revvity, Beckman Coulter and emerging players like QIAGEN and INTEGRA Biosciences. In 2025, the top five vendors captured roughly 30 % of global revenue, underscoring a moderately consolidated market. Surveyed stakeholders highlight trends toward modular, flexible platforms that can be rapidly re‑configured for DNA, RNA, or ChIP applications, and a shift toward subscription‑based service models to smooth capital expenditures. Regional analyses indicate that North America and Asia‑Pacific (particularly China and Japan) are the primary growth engines, with the U.S. and Chinese markets projected to dominate revenue share. The report also outlines detailed forecasts for market volume, segment percentages by type and application, and a comprehensive competitor matrix, providing strategic insights for investors and decision‑makers.
North America continues to dominate the Automated NGS Library Preparation System market, accounting for roughly 45 % of global revenue in 2025. The United States, the region’s cornerstone, benefits from a mature genomics ecosystem that includes major research institutions, large‑scale clinical testing labs, and a concentration of leading OEMs such as Illumina, Perkin Elmer and Beckman Coulter. Federal funding programmes, including the NIH’s $1.5 billion investment in genomic research for the 2022‑2027 period, have accelerated the adoption of high‑throughput library preparation platforms in both academic and commercial settings. Moreover, the rapid expansion of personalized‑medicine initiatives among major pharmaceutical companies drives demand for automated, high‑accuracy library construction to support large‑scale biomarker discovery. The region’s strong regulatory framework, particularly the FDA’s guidance on next‑generation sequencing (NGS) diagnostics, further underpins market confidence and encourages the rollout of fully automated solutions in clinical laboratories. While the market is mature, growth is sustained at a modest 7‑9 % CAGR through 2032, powered by continuous workflow optimisation, integration of AI‑driven quality control, and the shift of smaller labs toward turnkey automation to reduce hands‑on time and error rates.
Key Highlights:
Europe is expected to post a compound annual growth rate of approximately 11 % between 2026 and 2032, positioning the continent as the second‑largest market after North America. The European Union’s Horizon 2020 and Horizon Europe programmes have earmarked more than €2 billion for genomics, bioinformatics and health‑data integration, stimulating demand for high‑throughput, reproducible library preparation solutions. Countries such as Germany, the United Kingdom, France and the Nordic states host world‑class sequencing facilities (e.g., the European Bioinformatics Institute in Hinxton and the German Cancer Research Center) that require fully automated pipelines to maintain throughput and data quality. In addition, the implementation of the EU Clinical Trials Regulation (EU‑CTR) facilitates multinational clinical sequencing studies, driving harmonised adoption of automated NGS workflows across borders. The region also benefits from a growing market for liquid‑biopsy diagnostics, especially in oncology, where modular library‑prep systems enable rapid turnaround times essential for companion‑diagnostic testing. While the market is expanding, manufacturers must navigate fragmented procurement processes across member states and align with stringent data‑privacy regulations (GDPR), which can lengthen sales cycles.
Key Highlights:
Asia‑Pacific is projected to become the fastest‑growing market, with a CAGR of 14 % through 2032, driven primarily by China, Japan, South Korea and India. China’s “Healthy China 2030” plan and the National 1 + 3 Genomics Initiative allocate substantial resources to build nation‑wide sequencing infrastructure, resulting in a surge of automated library‑prep installations in national reference labs and emerging private genomics companies. Japan’s focus on precision oncology, bolstered by the “Cancer Genome Medicine” project, pushes hospitals toward fully automated NGS pipelines to meet the demand for rapid turnaround in companion‑diagnostic testing. South Korea’s substantial investment in bio‑convergence, exceeding $10 billion annually, fuels the adoption of modular, high‑speed library‑prep systems in both research and commercial sectors. India, with its burgeoning biotech ecosystem and government‑backed “India Genome Project,” is witnessing rapid uptake of cost‑effective automation to democratise sequencing across academic and diagnostic labs. The region’s large‑scale population health initiatives, coupled with aggressive rollout of population‑scale whole‑genome sequencing in China and Japan, create a strong demand for systems that deliver high accuracy, low error rates and scalable throughput. Market participants are establishing regional R&D centres and local manufacturing to meet price‑sensitivity and supply‑chain expectations.
Key Highlights:
Brazil and Argentina lead the South‑American market, together representing over 70 % of regional revenue in 2025. Brazil’s government‑backed “Genomics Brazil” program, with an investment of $250 million, aims to establish a national sequencing network to support public‑health surveillance and agricultural genomics, prompting hospitals and research institutes to acquire fully automated library‑prep platforms. Argentina’s emphasis on precision agriculture and its growing biotech sector have attracted foreign OEMs to set up regional distribution hubs, ensuring faster delivery and localized technical support. Chile and Colombia are emerging as secondary markets, driven by investments in infectious‑disease monitoring (e.g., Zika, COVID‑19) and an expanding academic research base. The region benefits from relatively lower labor costs, which makes the total cost of ownership of automated systems attractive compared with manual workflows. However, challenges such as fragmented funding mechanisms, import‑tariff barriers and the need for skilled bio‑informatics personnel temper growth, prompting OEMs to offer comprehensive training and service packages.
Key Highlights:
The Middle East & Africa (ME&A) region is projected to grow at a CAGR of 9 % through 2032, spurred by ambitious healthcare‑modernisation programmes in the Gulf Cooperation Council (GCC) and expanding research capacity in South Africa. Saudi Arabia’s Vision 2030 allocates $2 billion for genomic‑medicine infrastructure, including the establishment of a national NGS centre that requires high‑throughput, fully automated library preparation to support precision‑health initiatives. The United Arab Emirates has launched the “Genomics Strategic Initiative,” focusing on rare‑disease diagnostics and population‑scale sequencing, driving demand for modular automation that can be quickly scaled in both public hospitals and private diagnostic firms. South Africa, as the continent’s most advanced genomic research hub, is increasing investment in next‑generation sequencing platforms for cancer genomics and infectious‑disease surveillance, creating a niche for cost‑effective, rugged automated systems suitable for varying laboratory environments. While funding is increasing, the market still faces challenges related to limited local expertise, regulatory heterogeneity, and the need for robust supply‑chain logistics. OEMs are responding by establishing regional training centres, offering flexible financing models, and ensuring compliance with diverse regulatory frameworks across the region.
Key Highlights:
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
✅ Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
✅ Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
✅ Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
✅ Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
✅ Stakeholder Insights
Target audience includes manufacturers, suppliers, distributors, investors, regulators, and policymakers
-> Key players include PerkinElmer, Agilent Technologies, Tecan, Illumina, Roche, Takara Bio USA, Aurora Biomed, Hamilton, Revvity, Beckman Coulter, QIAGEN, INTEGRA Biosciences AG, SPT Labtech, AUTOMATA, Guangdong MGI Tech, Jiangsu Bioperfectus Technologies, among others.
-> Growth is driven by rapid expansion of genomics research, increasing demand for high‑throughput sequencing in clinical diagnostics, the need for workflow automation to reduce error rates, and rising investment in precision medicine initiatives worldwide.
-> North America holds the largest share due to early adoption of advanced sequencing platforms, while Asia‑Pacific is the fastest‑growing region, propelled by large‑scale research programs in China, Japan, and South Korea.
-> Emerging trends include AI‑enhanced liquid‑handling algorithms, modular and scalable system architectures, integration of cloud‑based data analytics, and sustainability‑focused designs that minimize reagent waste.
